Get the Stockscreener App
113.21
1.37%
-1.5891
Repligen Corp stock is traded at $113.21, with a volume of 1.11M.
It is down -1.37% in the last 24 hours and down -4.73% over the past month.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.
See More
Previous Close:
$114.80
Open:
$113.45
24h Volume:
1.11M
Relative Volume:
1.43
Market Cap:
$6.36B
Revenue:
$633.51M
Net Income/Loss:
$-8.10M
P/E Ratio:
-365.20
EPS:
-0.31
Net Cash Flow:
$131.26M
1W Performance:
-4.12%
1M Performance:
-4.73%
6M Performance:
-32.13%
1Y Performance:
-12.62%
1-Day Range:
$110.85
$115.65
1-Week Range:
$110.85
$125.00
52-Week Range:
$102.97
$182.52
Repligen Corp Stock (RGEN) Company Profile
Name
Repligen Corp
Sector
Industry
Phone
(781) 449-9560
Address
41 SEYON STREET, WALTHAM, MA
Compare RGEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RGEN
Repligen Corp
|
113.22 | 6.82B | 633.51M | -8.10M | 131.26M | -0.31 |
|
ISRG
Intuitive Surgical Inc
|
513.15 | 185.10B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
180.87 | 50.76B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
88.30 | 43.19B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
267.97 | 37.26B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
217.25 | 16.13B | 2.90B | 467.20M | 306.90M | 6.37 |
Repligen Corp Stock (RGEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-24-25 | Initiated | Barclays | Overweight |
| Apr-29-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Mar-18-25 | Initiated | Evercore ISI | In-line |
| Feb-10-25 | Initiated | TD Cowen | Buy |
| Dec-17-24 | Initiated | Canaccord Genuity | Hold |
| Nov-14-24 | Initiated | Wolfe Research | Peer Perform |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-26-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Jun-18-24 | Initiated | Guggenheim | Neutral |
| Dec-04-23 | Downgrade | The Benchmark Company | Buy → Hold |
| Jul-20-23 | Initiated | Wells Fargo | Overweight |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| Mar-28-23 | Initiated | The Benchmark Company | Buy |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Dec-07-22 | Initiated | RBC Capital Mkts | Sector Perform |
| Jul-20-22 | Initiated | UBS | Buy |
| Oct-14-21 | Initiated | Exane BNP Paribas | Outperform |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Aug-24-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-30-20 | Reiterated | H.C. Wainwright | Buy |
| May-07-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-23-20 | Reiterated | H.C. Wainwright | Buy |
| Nov-15-19 | Initiated | Stifel | Buy |
| Nov-01-19 | Upgrade | First Analysis Sec | Outperform → Strong Buy |
| Oct-15-19 | Initiated | SVB Leerink | Outperform |
| Aug-28-19 | Reiterated | First Analysis Sec | Outperform |
| Aug-23-19 | Resumed | Stephens | Overweight |
| Jul-22-19 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Dec-17-18 | Upgrade | CL King | Neutral → Buy |
| Nov-12-18 | Downgrade | CL King | Buy → Neutral |
| Sep-26-18 | Initiated | H.C. Wainwright | Neutral |
| Dec-08-17 | Initiated | Citigroup | Buy |
| Dec-05-17 | Initiated | JP Morgan | Overweight |
| Nov-13-17 | Initiated | CL King | Buy |
| Oct-02-17 | Upgrade | First Analysis Sec | Equal-Weight → Overweight |
| Jul-21-17 | Initiated | William Blair | Outperform |
| Feb-13-17 | Upgrade | Piper Jaffray | Neutral → Overweight |
View All
Repligen Corp Stock (RGEN) Latest News
Repligen (RGEN) Receives Overweight Rating with $160 Price Targe - GuruFocus
Here's Why Repligen (RGEN) is a Strong Growth Stock - Yahoo Finance
Repligen FY2025 EPS Forecast Increased by Leerink Partnrs - Defense World
What analysts say about Repligen Corporation stockExplosive portfolio gains - printweek.in
Envestnet Asset Management Inc. Reduces Position in Repligen Corporation (NASDAQ:RGEN) - Defense World
Repligen Corp to Release Q2 2025 Financial Results and Host Conference Call on July 29, 2025. - AInvest
Repligen, Bruker, Fortrea, Azenta, and Biogen Stocks Trade Down, What You Need To Know - Yahoo Finance
M&T Bank Corp Reduces Stake in Repligen Corporation (NASDAQ:RGEN) - Defense World
Repligen to Report Second Quarter 2025 Financial Results - The Globe and Mail
Repligen Corporation to Announce Second Quarter 2025 Financial Results on July 29 - Quiver Quantitative
How KEY.PRK stock performs during market volatilityFree Consultation - Newser
Why DOCU stock attracts strong analyst attentionHigh Potential Shares - Newser
How Life360 Inc. stock performs during market volatilityFree Stock Market Knowledge Sharing - Newser
Protein Purification and Isolation Market Size to Surpass USD 33.02 Billion by 2034 - BioSpace
Parnassus Mid Cap Growth Fund Q2 2025 Commentary - Seeking Alpha
Parnassus Mid Cap Fund Q2 2025 Commentary - Seeking Alpha
Why Repligen Corporation stock attracts strong analyst attentionInstant Stock Updates - Newser
What makes ScanSource Inc. stock price move sharplyFree Stock Market Forecasting Tools - Newser
What makes HUTCHMED (China) Limited Depositary Receipt stock price move sharplyFree Join Group - Newser
How Repligen Corporation stock performs during market volatility200 Percent Profit Outlook - Newser
Why Sphere 3D Corp. stock attracts strong analyst attentionFree Stock Trading Community - Newser
Why ROAD stock attracts strong analyst attentionTop Analyst Picks - Newser
Evercore ISI Cuts Repligen (NASDAQ:RGEN) Price Target to $130.00 - Defense World
Repligen And 2 Other Stocks That May Be Trading Below Estimated Value - Yahoo Finance
GAMMA Investing LLC Boosts Holdings in Repligen Corporation (NASDAQ:RGEN) - Defense World
Repligen Corporation (NASDAQ:RGEN) Shares Purchased by KBC Group NV - Defense World
Fluor Corporation (NYSE:FLR) Shares Sold by Amalgamated Bank - Defense World
Wall Street Zen Downgrades Repligen (NASDAQ:RGEN) to Hold - Defense World
Improving Process Reliability in mAb Manufacturing - Genetic Engineering and Biotechnology News
Barclays initiates Repligen stock with overweight rating on bioprocessing strength - Investing.com
Sarepta Therapeutics, KULR Technology Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Yousif Capital Management LLC Has $2.01 Million Position in Repligen Co. (NASDAQ:RGEN) - Defense World
Does Repligen Corp (RGEN) Have a Strong Pricing Power? - Insider Monkey
Repligen Co. (NASDAQ:RGEN) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Parallel Advisors LLC Has $36,000 Stock Holdings in Repligen Co. (NASDAQ:RGEN) - Defense World
Three Stocks That May Be Trading Below Their Intrinsic Value In June 2025 - Yahoo Finance
Winners And Losers Of Q1: Repligen (NASDAQ:RGEN) Vs The Rest Of The Drug Development Inputs & Services Stocks - Yahoo Finance
Repligen at William Blair Conference: Innovation Drives Growth By Investing.com - Investing.com Canada
Repligen at William Blair Conference: Innovation Drives Growth - Investing.com
Repligen Corp (RGEN) Stock Price Up 5% on Jun 3 - GuruFocus
Drug Development Inputs & Services Stocks Q1 In Review: Repligen (NASDAQ:RGEN) Vs Peers - Yahoo Finance
Do Options Traders Know Something About Repligen (RGEN) Stock We Don't? - Yahoo Finance
Repligen Corp (RGEN) Trading Down 3.33% on May 30 - GuruFocus
Why Is Repligen (RGEN) Down 12.2% Since Last Earnings Report? - Yahoo Finance
Cetera Investment Advisers Has $436,000 Position in Repligen Co. (NASDAQ:RGEN) - Defense World
Repligen Corp (RGEN) Stock Price Up 4.35% on May 27 - GuruFocus
Repligen Announces Publication of the Company's 2024 Corporate Sustainability Report - The Manila Times
Repligen Announces Publication of the Company’s 2024 Corporate Sustainability Report - TradingView
Repligen’s SWOT analysis: bioprocessing leader’s stock faces growth challenges - Investing.com
Repligen’s SWOT analysis: bioprocessing leader’s stock faces growth challenges By Investing.com - Investing.com UK
Repligen Corporation to Present at William Blair Growth Conference - Yahoo Finance
Repligen Corp Stock (RGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.60%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):